Study Evaluating the Helical Ureteral Stent

University of British Columbia17 enrolled

Overview

The Boston Scientific Helical Stent is a unique stent designed to improve flexibility and comfort. It is designed to conform more to the shape of the ureter (hollow tube connecting the kidney and the bladder) to ultimately improve patient comfort and decrease the need for painkillers.

Ureteral stents have been used for many years for a variety of clinical indications. Many surgeons routinely use ureteral stents after the endourologic removal of stones to facilitate in urine passage and facilitate excretion of any left over stones. There is a multitude of literature that reveals that most patients find ureteral stents to be uncomfortable. This discomfort often causes pain severe enough that patients anxiously anticipate stent removal, and often request early stent removal, and/or require use of pain medications that have many side effects and cause further discomfort to these patients.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Kidney Calculi

Interventions

Stent insertionDEVICE

The patient will receive the helical stent

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Male or female; female patients must be sterile, post-menopausal or willing to use birth control during the course of the study 2. 19 years of age and older 3. Having undergone Shockwave Lithotripsy-SWL, or a diagnostic ureteroscopy or uncomplicated ureteroscopy for stone removal requiring retrograde placement of a ureteral stent for an anticipated duration of between 2 and 21 days 4. Willing to sign the Informed Consent Form 5. Able to read, understand, and complete patient questionnaires Exclusion Criteria: 1. Active, symptomatic urinary tract infection 2. Non-stone related distal ureteral obstruction or stricture 3. Clinically significant trauma or significant retained stone burden that could significantly contribute to patient discomfort 4. Ureteral perforation or trauma 5. History of bladder reconstruction or interstitial cystitis 6. Spinal cord injuries 6\. Pregnant or lactating females 7. Non-stone related voiding dysfunction requiring supplemental bladder drainage tubes for more than 24 hours post operatively 8. Patients with a solitary kidney 9. Chronic use of pain or anti-spasmodic medication for symptoms other than stone related pain 10. If in the opinion of the Investigator, the patient is not a suitable study candidate.

Locations (1)

University of British Columbia

Vancouver, British Columbia, Canada

Outcomes

Primary Outcomes

Percent of patients who have pain during the stent indwell period

The primary objective is to decrease the percent of patients who have pain during the stent indwell period beyond protocol-defined postoperative pain therapy from 25% for standard stents (the Control Stent in previous studies) to 10% for the Helical Stent. The previous clinical trial found that patients with Percuflex Plus stents had pain 25.2% of the time following stent insertion (J Urol 183:1037, 2010).

Time frame: 1-2 weeks

Secondary Outcomes

Percent of patients requesting intervention during the stent indwell period

The secondary objective is to decrease the percent of patients requesting intervention during the stent indwell period. Interventions are defined as the following actions taken due to pain: 1. Unscheduled Clinic visit, or 2. Change in Pain Medication, or 3. Early Stent Removal

Time frame: 1-2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.